# Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy

> **NCT04053842** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Glenn Bauman** · enrollment: 45 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Prostate Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** PET Scan
- **DRUG:** [18F]PSMA-1007 Injection
- **DIAGNOSTIC_TEST:** Sodium MRI
- **DIAGNOSTIC_TEST:** Multiparametric MRI

## Key facts

- **NCT ID:** NCT04053842
- **Lead sponsor:** Glenn Bauman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-04
- **Primary completion:** 2024-01-23
- **Final completion:** 2025-09
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053842, "Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04053842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*